IPO Archives - Pharmaphorum

Cancer blood test firm Grail mulls IPO

https://pharmaphorum.com/news/cancer-blood-test-firm-grail-mulls-hong-kong-ipo/

Apitope announces IPO to fund MS drug development

https://pharmaphorum.com/news/apitope-announces-ipo-fund-ms-drug-development/

Biofrontera mulls US IPO to fund skin cancer drug

https://pharmaphorum.com/news/biofrontera-considers-us-listing-fund-skin-cancer-drug/

Clovis looks for new drugs after Rubraca success

https://pharmaphorum.com/news/clovis-looks-new-drugs-rubraca-success/

Biotech IPO market heats up as BioHaven’s debut impresses

https://pharmaphorum.com/news/biotech-ipo-market-heats-biohaven-makes-debut/

Are biotech IPOs back in fashion?

https://pharmaphorum.com/news/biotech-ipos-coming-back-fashion/

Tocagen aims for IPO to fund brain cancer trial

https://pharmaphorum.com/news/tocagen-aims-ipo-fund-brain-cancer-trial/

Jounce set to make first biotech IPO of 2017

https://pharmaphorum.com/news/jounce-gets-early-lead-2017-biotech-ipos/

CRISPR Therapeutics plans Nasdaq launch

https://pharmaphorum.com/news/crispr-therapeutics-plans-nasdaq-launch/

Search